<DOC>
	<DOC>NCT00813306</DOC>
	<brief_summary>The purpose of the study is to assess the safety and tolerability of AZD2066 and to explore the effect of a single dose of AZD2066 on the function of the cardia (the opening between the stomach and the esophagus) compared to placebo (not containing any medical substance) in healthy volunteers.</brief_summary>
	<brief_title>14473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter Relaxations</brief_title>
	<detailed_description />
	<criteria>Provision of written consent prior to any study specific procedures. Healthy subjects, age 1845 years inclusive. Females must be of no childbearing potential or must use a highly effective contraceptive method. Clinically normal physical findings and laboratory values at the time of preentry visit, as judged by the investigator. Clinically significant illness within the 2 weeks prior to the first dose of the investigational product, including a suspected/manifested infection according to WHO risk categories 2, 3 or 4, as judged by the investigator. A measured LES pressure of &lt; 5mm Hg. History of previous or ongoing psychiatric disease/condition.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>GERD</keyword>
	<keyword>TLESR</keyword>
	<keyword>reflux</keyword>
</DOC>